Results 51 to 60 of about 2,856,528 (208)

The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers

open access: yesПроблемы особо опасных инфекций, 2018
Presently, the Arenavirus genus (Arenaviridae family) includes 26 individual species of viruses. It is divided into two main groups – Old World arenaviruses and New World arenaviruses.
T. E. Sizikova   +3 more
doaj   +1 more source

Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus [PDF]

open access: yes, 1994
The sequence of the gene encoding glycoprotein H (gH) of murine cytomegalovirus (MCMV) strain Smith was determined and compared with the sequence of the gH of MCMV strain K181. Transcriptional analysis showed that gH is encoded by a large mRNA of 5.0 kb,
Koszinowski, Ulrich H.   +4 more
core   +1 more source

Liposome‐mediated DNA vaccination [PDF]

open access: yesFEBS Letters, 1997
Numerous reports have indicated that intramuscular injection of antigen‐coding naked plasmid DNA can trigger humoral and cell‐mediated protective immunity against infection. This follows DNA uptake by muscle fibres, leading to the expression and extracellular release of the antigen. Here it is shown for the first time that intramuscular immunization of
Gregoriadis, Gregory   +2 more
openaire   +2 more sources

Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment

open access: yesFrontiers in Bioengineering and Biotechnology, 2021
DNA vaccines, the third generation of vaccines, are a promising therapeutic option for many diseases as they offer the customization of their ability on protection and treatment with high stability.
Lalintip Hocharoen   +2 more
doaj   +1 more source

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein

open access: yesScientific Reports, 2017
MERS-coronavirus is a novel zoonotic pathogen which spread rapidly to >25 countries since 2012. Its apparent endemicity and the wide spread of its reservoir host (dromedary camels) in the Arabian Peninsula highlight the ongoing public health threat of ...
Sawsan S. Al-amri   +9 more
semanticscholar   +1 more source

Population, sexual and reproductive health, rights and sustainable development: forging a common agenda. [PDF]

open access: yes, 2010
This article suggests that sexual and reproductive health and rights activists seeking to influence the post-2015 international development paradigm must work with sustainable development advocates concerned with a range of issues, including climate ...
Campbell, D. M.   +11 more
core   +1 more source

DNA vaccines [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2013
Since the introduction of DNA vaccines two decades ago, this attractive strategy has been hampered by its low immunogenicity in humans. Studies conducted to improve the immunogenicity of DNA vaccines have shown that understanding the mechanism of action of DNA vaccines might be the key to successfully improving their immunogenicity.
Coban, Cevayir   +4 more
openaire   +2 more sources

Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases

open access: yesHuman Gene Therapy, 2018
Human papillomavirus (HPV) has long been recognized as the causative agent of cervical cancer. High-risk HPV types 16 and 18 alone are responsible for over 70% of all cases of cervical cancers.
Max A. Cheng   +5 more
semanticscholar   +1 more source

Accelerating vaccine development and deployment: report of a Royal Society satellite meeting. [PDF]

open access: yes, 2011
The Royal Society convened a meeting on the 17th and 18th November 2010 to review the current ways in which vaccines are developed and deployed, and to make recommendations as to how each of these processes might be accelerated.
Bregu, Migena   +3 more
core   +2 more sources

Molecular Adjuvants for DNA Vaccines.

open access: yesCurrent Issues in Molecular Biology, 2017
Poor immunogenicity remains the single biggest obstacle to human DNA vaccines achieving their potential. Strategies to improve DNA vaccine efficacy include codon optimization, transfection reagents, electroporation, vaccine adjuvants or combination with ...
Lei Li, N. Petrovsky
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy